Close

Our Story

Our Story

POA Pharma is committed to partnering with like-minded companies to deliver innovation, quality and value to healthcare professionals and their patients.

We are a speciality pharmaceutical company with expertise in several therapeutic areas.

The POA Pharma team has extensive expertise in supporting partners, healthcare professionals and patients within Europe. We benefit from being part of the wider Galen network, with its substantial infrastructure and the support services that come with a multinational company, providing the strategy and resources to help deliver POA Pharma’s growth plans.

POA Pharma

With headquarters based in Copenhagen, POA Pharma, currently collaborates with 13 partners in 10 countries.

POA Pharma is part of Galen Limited, a privately owned company established in 1968, with global headquarters in Craigavon, Northern Ireland, and commercial operations based in the UK, Ireland, the Nordics, Germany, Austria, the Netherlands and the USA.

Galen was founded in Northern Ireland in 1968 by the late Sir Allen McClay (d.2010), the revered philanthropist and entrepreneur.

"At POA Pharma we have purpose and passion in everything we do and encourage our people to dare to be extraordinary so we can benefit the health of all generations."

Over 50 years of successful growth

2024

POA Pharma GmbH entered Austria and the Netherlands

2023

POA Pharma GmbH was founded

2020

POA Pharma Copenhagen office opens

2017

Galen Acquired POA Pharma

2011

Galen US Inc established

2010

Sir Allen McClay passed away

2004

Sir Allen McClay purchased Galen Ltd

2002

Sir Allen McClay formed Almac

2000

Galen purchased US company Warner Chilcott

1997

Galen Plc floated on the stock market (NI’s first £1 Billion company)

1978

Commercial manufacturing of Galen Products (Craigavon)

1968

Sir Allen McClay founded Galen Ltd

You are about to leave this website to go to an external website.

POA Pharma does not take any responsibility for content hosted on external websites.

Click to proceed
By using this website, you agree to the terms of the site and use of cookies as described in our Privacy Policy.